Literature DB >> 27867651

Dexmedetomidine, agitated delirium, and "off-label" drugs.

Genís Carrasco1, Nacho Baeza1, Lluís Cabré1.   

Abstract

Entities:  

Year:  2016        PMID： 27867651      PMCID： PMC5107461          DOI： 10.21037/jtd.2016.10.02

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  11 in total

1.  High-dose intravenous haloperidol for agitated delirium in a cardiac patient on intra-aortic balloon pump.

Authors:  K M Sanders; G B Murray; N H Cassem
Journal:  J Clin Psychopharmacol       Date:  1991-04       Impact factor: 3.153

2.  Controlling off-label medication use.

Authors:  Muriel R Gillick
Journal:  Ann Intern Med       Date:  2009-02-16       Impact factor: 25.391

3.  Dexmedetomidine for hyperactive delirium: worth further study.

Authors:  Melissa P Knauert; Margaret A Pisani
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

4.  Dexmedetomidine for the Treatment of Hyperactive Delirium Refractory to Haloperidol in Nonintubated ICU Patients: A Nonrandomized Controlled Trial.

Authors:  Genís Carrasco; Nacho Baeza; Lluís Cabré; Eugenia Portillo; Gemma Gimeno; David Manzanedo; Milagros Calizaya
Journal:  Crit Care Med       Date:  2016-07       Impact factor: 7.598

5.  Dexmedetomidine for the treatment of hyperactive delirium refractory to haloperidol in non-intubated patients.

Authors:  Ryan O Parker; Adam B King; Christopher G Hughes
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

6.  A Multicenter Evaluation of Off-Label Medication Use and Associated Adverse Drug Reactions in Adult Medical ICUs.

Authors:  Pamela L Smithburger; Mitchell S Buckley; Mark A Culver; Sarah Sokol; Ishaq Lat; Steven M Handler; Levent Kirisci; Sandra L Kane-Gill
Journal:  Crit Care Med       Date:  2015-08       Impact factor: 7.598

Review 7.  The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?

Authors:  Carla Meyer-Massetti; Christine M Cheng; Bradley A Sharpe; Christoph R Meier; B Joseph Guglielmo
Journal:  J Hosp Med       Date:  2010-04       Impact factor: 2.960

8.  Sedation and analgesia practices in neonatal intensive care units (EUROPAIN): results from a prospective cohort study.

Authors:  Ricardo Carbajal; Mats Eriksson; Emilie Courtois; Elaine Boyle; Alejandro Avila-Alvarez; Randi Dovland Andersen; Kosmas Sarafidis; Tarja Polkki; Cristina Matos; Paola Lago; Thalia Papadouri; Simon Attard Montalto; Mari-Liis Ilmoja; Sinno Simons; Rasa Tameliene; Bart van Overmeire; Angelika Berger; Anna Dobrzanska; Michael Schroth; Lena Bergqvist; Hugo Lagercrantz; Kanwaljeet J S Anand
Journal:  Lancet Respir Med       Date:  2015-09-24       Impact factor: 30.700

9.  Is off-label use a risk factor for adverse drug reactions in pediatric patients? A prospective study in an Indian tertiary care hospital.

Authors:  Mohd Masnoon Saiyed; Tarachand Lalwani; Devang Rana
Journal:  Int J Risk Saf Med       Date:  2015

Review 10.  Predicting, preventing, and identifying delirium after cardiac surgery.

Authors:  Jason B O'Neal; Andrew D Shaw
Journal:  Perioper Med (Lond)       Date:  2016-04-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.